• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消除宫颈癌:从卢旺达和澳大利亚吸取的经验教训。

Eradicating cervical cancer: Lessons learned from Rwanda and Australia.

机构信息

UCSF Institute for Health and Aging, San Francisco, CA, USA.

出版信息

Int J Gynaecol Obstet. 2021 Aug;154(2):270-276. doi: 10.1002/ijgo.13601. Epub 2021 Feb 23.

DOI:10.1002/ijgo.13601
PMID:33454969
Abstract

Both Rwanda and Australia have made significant strides to eradicate cervical cancer. To understand the successes in Rwanda and Australia, a comparative policy analysis was conducted based on key informant interviews and a review of peer-reviewed literature and policy briefs. Notable findings were identified that offer lessons for countries across the income spectrum. To address cervical cancer, low- and middle-income countries can leverage foreign aid, international collaboration, and strong political advocacy, as Rwanda did. High-income countries can invest in translational research that builds capacity from basic science research to implementation of novel and impactful health products and services, as Australia did. All countries can consider rolling out HPV vaccination by targeting the social and/or physical environment (e.g., a school-based vaccination program, as both Rwanda and Australia did). Cervical cancer is preventable, and eradication is within reach for countries across the income spectrum around the world. Cervical cancer screening programs are needed to minimize the incidence of and mortality from cervical cancer in the short term, and HPV vaccination programs are the best strategy to eradicate cervical cancer in the long term.

摘要

卢旺达和澳大利亚在消除宫颈癌方面都取得了重大进展。为了了解卢旺达和澳大利亚的成功经验,我们对关键知情人进行了访谈,并对同行评议文献和政策简报进行了审查,开展了比较政策分析。我们发现了一些显著的发现,这些发现为不同收入水平的国家提供了经验教训。为了解决宫颈癌问题,中低收入国家可以像卢旺达那样利用外援、国际合作和强有力的政治倡导。高收入国家可以投资于转化研究,从基础科学研究到实施新颖和有影响力的卫生产品和服务,就像澳大利亚所做的那样。所有国家都可以考虑通过针对社会和/或物理环境(例如,在学校开展疫苗接种计划,卢旺达和澳大利亚都这样做)推出 HPV 疫苗接种。宫颈癌是可以预防的,全世界不同收入水平的国家都有希望消除宫颈癌。宫颈癌筛查计划对于短期降低宫颈癌发病率和死亡率是必要的,而 HPV 疫苗接种计划是长期消除宫颈癌的最佳策略。

相似文献

1
Eradicating cervical cancer: Lessons learned from Rwanda and Australia.消除宫颈癌:从卢旺达和澳大利亚吸取的经验教训。
Int J Gynaecol Obstet. 2021 Aug;154(2):270-276. doi: 10.1002/ijgo.13601. Epub 2021 Feb 23.
2
Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.2009年至2014年在19个低收入和中等收入国家实施的29项人乳头瘤病毒疫苗接种项目的经验与教训。
BMC Health Serv Res. 2016 Oct 13;16(1):575. doi: 10.1186/s12913-016-1824-5.
3
What works for human papillomavirus vaccine introduction in low and middle-income countries?在低收入和中等收入国家引入人乳头瘤病毒疫苗,有哪些可行的做法?
Papillomavirus Res. 2017 Dec;4:22-25. doi: 10.1016/j.pvr.2017.06.003. Epub 2017 Jun 8.
4
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.人乳头瘤病毒在俄罗斯联邦、前苏联西方国家、高加索地区和中亚的流行情况和型别分布、宫颈癌筛查实践以及疫苗接种实施现状。
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
5
Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.6 个非洲国家在国家引入人乳头瘤病毒(HPV)疫苗接种规划期间的经验教训:利益攸关方的观点。
S Afr Med J. 2020 May 29;110(6):525-531. doi: 10.7196/SAMJ.2020.v110i6.14332.
6
Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan.卢旺达和不丹的人乳头瘤病毒疫苗接种影响。
Emerg Infect Dis. 2021 Jan;27(1):1-9. doi: 10.3201/eid2701.191364.
7
Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.在卢旺达国家人乳头瘤病毒疫苗接种计划中实现高覆盖率。
Bull World Health Organ. 2012 Aug 1;90(8):623-8. doi: 10.2471/BLT.11.097253. Epub 2012 May 23.
8
Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.预防性人乳头瘤病毒疫苗接种与宫颈癌的一级预防:问题与挑战。
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6.
9
Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.南澳大利亚实施人乳头瘤病毒学校疫苗接种计划后的挑战、经验教训及成果
Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x.
10
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.预防宫颈癌:国家乳腺癌和宫颈癌早期检测计划及两项美国免疫计划概述
Cancer. 2008 Nov 15;113(10 Suppl):3004-12. doi: 10.1002/cncr.23765.

引用本文的文献

1
Empowering India's fight against cervical cancer: Harnessing routine HPV immunisation.助力印度抗击宫颈癌:利用常规人乳头瘤病毒免疫接种
J Family Med Prim Care. 2025 Jan;14(1):22-28. doi: 10.4103/jfmpc.jfmpc_678_24. Epub 2025 Jan 13.
2
Mobilizing stakeholders to drive the cervical cancer elimination agenda in Kenya: The national cervical cancer stakeholders' forum 2022.动员利益相关者推动肯尼亚消除宫颈癌议程:2022年全国宫颈癌利益相关者论坛
Dialogues Health. 2022 Oct 30;1:100066. doi: 10.1016/j.dialog.2022.100066. eCollection 2022 Dec.
3
Understanding HPV Vaccination Policymaking in Rwanda: A Case of Health Prioritization and Public-Private-Partnership in a Low-Resource Setting.
了解卢旺达的 HPV 疫苗接种政策制定:在资源有限的环境下进行卫生重点排序和公私合作伙伴关系的案例。
Int J Environ Res Public Health. 2023 Oct 30;20(21):6998. doi: 10.3390/ijerph20216998.
4
Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?规划、实施和维持高覆盖率的人乳头瘤病毒(HPV)疫苗接种计划:在资源有限的国家背景下,哪些措施有效?
Front Public Health. 2023 Apr 14;11:1112981. doi: 10.3389/fpubh.2023.1112981. eCollection 2023.
5
Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.治疗后宫颈癌患者的性功能和生活质量:系统评价。
Medicina (Kaunas). 2023 Apr 4;59(4):704. doi: 10.3390/medicina59040704.
6
Universal Cervical Cancer Immunization: India Ready for a Quantum Leap.宫颈癌全民免疫:印度准备好实现重大飞跃。
J Midlife Health. 2022 Jul-Sep;13(3):260-262. doi: 10.4103/jmh.jmh_224_22. Epub 2023 Jan 14.
7
Updates on HPV Vaccination.人乳头瘤病毒疫苗最新情况
Diagnostics (Basel). 2023 Jan 9;13(2):243. doi: 10.3390/diagnostics13020243.
8
Cervical cancer in Nepal: Current screening strategies and challenges.尼泊尔的宫颈癌:现行筛查策略和挑战。
Front Public Health. 2022 Nov 17;10:980899. doi: 10.3389/fpubh.2022.980899. eCollection 2022.
9
Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.数千名女性的生命取决于波兰宫颈癌筛查与预防教育的改善以及宫颈癌防治机构之间更好的网络策略。
Diagnostics (Basel). 2022 Jul 26;12(8):1807. doi: 10.3390/diagnostics12081807.
10
Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease.2019 年全球宫颈癌发病率和死亡率的趋势和年龄特异性:基于全球疾病负担的国际比较研究。
BMJ Open. 2022 Jul 22;12(7):e055470. doi: 10.1136/bmjopen-2021-055470.